Cargando…

Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure

BACKGROUND: Recent advances in large datasets analysis offer new insights to modern biology allowing system-level investigation of pathologies. Here we describe a novel computational method that exploits the ever-growing amount of “omics” data to shed light on Alzheimer’s and Parkinson’s diseases. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderone, Alberto, Formenti, Matteo, Aprea, Federica, Papa, Michele, Alberghina, Lilia, Colangelo, Anna Maria, Bertolazzi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776441/
https://www.ncbi.nlm.nih.gov/pubmed/26935435
http://dx.doi.org/10.1186/s12918-016-0270-7
_version_ 1782419157541715968
author Calderone, Alberto
Formenti, Matteo
Aprea, Federica
Papa, Michele
Alberghina, Lilia
Colangelo, Anna Maria
Bertolazzi, Paola
author_facet Calderone, Alberto
Formenti, Matteo
Aprea, Federica
Papa, Michele
Alberghina, Lilia
Colangelo, Anna Maria
Bertolazzi, Paola
author_sort Calderone, Alberto
collection PubMed
description BACKGROUND: Recent advances in large datasets analysis offer new insights to modern biology allowing system-level investigation of pathologies. Here we describe a novel computational method that exploits the ever-growing amount of “omics” data to shed light on Alzheimer’s and Parkinson’s diseases. Neurological disorders exhibit a huge number of molecular alterations due to a complex interplay between genetic and environmental factors. Classical reductionist approaches are focused on a few elements, providing a narrow overview of the etiopathogenic complexity of multifactorial diseases. On the other hand, high-throughput technologies allow the evaluation of many components of biological systems and their behaviors. Analysis of Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) from a network perspective can highlight proteins or pathways common but differently represented that can be discriminating between the two pathological conditions, thus highlight similarities and differences. RESULTS: In this work we propose a strategy that exploits network community structure identified with a state-of-the-art network community discovery algorithm called InfoMap, which takes advantage of information theory principles. We used two similarity measurements to quantify functional and topological similarities between the two pathologies. We built a Similarity Matrix to highlight similar communities and we analyzed statistically significant GO terms found in clustered areas of the matrix and in network communities. Our strategy allowed us to identify common known and unknown processes including DNA repair, RNA metabolism and glucose metabolism not detected with simple GO enrichment analysis. In particular, we were able to capture the connection between mitochondrial dysfunction and metabolism (glucose and glutamate/glutamine). CONCLUSIONS: This approach allows the identification of communities present in both pathologies which highlight common biological processes. Conversely, the identification of communities without any counterpart can be used to investigate processes that are characteristic of only one of the two pathologies. In general, the same strategy can be applied to compare any pair of biological networks. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-016-0270-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4776441
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47764412016-03-04 Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure Calderone, Alberto Formenti, Matteo Aprea, Federica Papa, Michele Alberghina, Lilia Colangelo, Anna Maria Bertolazzi, Paola BMC Syst Biol Methodology Article BACKGROUND: Recent advances in large datasets analysis offer new insights to modern biology allowing system-level investigation of pathologies. Here we describe a novel computational method that exploits the ever-growing amount of “omics” data to shed light on Alzheimer’s and Parkinson’s diseases. Neurological disorders exhibit a huge number of molecular alterations due to a complex interplay between genetic and environmental factors. Classical reductionist approaches are focused on a few elements, providing a narrow overview of the etiopathogenic complexity of multifactorial diseases. On the other hand, high-throughput technologies allow the evaluation of many components of biological systems and their behaviors. Analysis of Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) from a network perspective can highlight proteins or pathways common but differently represented that can be discriminating between the two pathological conditions, thus highlight similarities and differences. RESULTS: In this work we propose a strategy that exploits network community structure identified with a state-of-the-art network community discovery algorithm called InfoMap, which takes advantage of information theory principles. We used two similarity measurements to quantify functional and topological similarities between the two pathologies. We built a Similarity Matrix to highlight similar communities and we analyzed statistically significant GO terms found in clustered areas of the matrix and in network communities. Our strategy allowed us to identify common known and unknown processes including DNA repair, RNA metabolism and glucose metabolism not detected with simple GO enrichment analysis. In particular, we were able to capture the connection between mitochondrial dysfunction and metabolism (glucose and glutamate/glutamine). CONCLUSIONS: This approach allows the identification of communities present in both pathologies which highlight common biological processes. Conversely, the identification of communities without any counterpart can be used to investigate processes that are characteristic of only one of the two pathologies. In general, the same strategy can be applied to compare any pair of biological networks. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-016-0270-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-02 /pmc/articles/PMC4776441/ /pubmed/26935435 http://dx.doi.org/10.1186/s12918-016-0270-7 Text en © Calderone et al. 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Calderone, Alberto
Formenti, Matteo
Aprea, Federica
Papa, Michele
Alberghina, Lilia
Colangelo, Anna Maria
Bertolazzi, Paola
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title_full Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title_fullStr Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title_full_unstemmed Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title_short Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
title_sort comparing alzheimer’s and parkinson’s diseases networks using graph communities structure
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776441/
https://www.ncbi.nlm.nih.gov/pubmed/26935435
http://dx.doi.org/10.1186/s12918-016-0270-7
work_keys_str_mv AT calderonealberto comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT formentimatteo comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT apreafederica comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT papamichele comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT alberghinalilia comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT colangeloannamaria comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure
AT bertolazzipaola comparingalzheimersandparkinsonsdiseasesnetworksusinggraphcommunitiesstructure